Literature DB >> 16562997

Molecular field extrema as descriptors of biological activity: definition and validation.

Tim Cheeseright1, Mark Mackey, Sally Rose, Andy Vinter.   

Abstract

The paper describes the generation of four types of three-dimensional molecular field descriptors or 'field points' as extrema of electrostatic, steric, and hydrophobic fields. These field points are used to define the properties necessary for a molecule to bind in a characteristic way into a specified active site. The hypothesis is that compounds showing a similar field point pattern are likely to bind at the same target site regardless of structure. The methodology to test this idea is illustrated using HIV NNRTI and thrombin ligands and validated across seven other targets. From the in silico comparisons of field point overlays, the experimentally observed binding poses of these ligands in their respective sites can be reproduced from pairwise comparisons.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16562997     DOI: 10.1021/ci050357s

Source DB:  PubMed          Journal:  J Chem Inf Model        ISSN: 1549-9596            Impact factor:   4.956


  82 in total

1.  Modulation of 11beta-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles.

Authors:  Scott P Webster; Margaret Binnie; Kirsty M M McConnell; Karen Sooy; Peter Ward; Michael F Greaney; Andy Vinter; T David Pallin; Hazel J Dyke; Matthew I A Gill; Ines Warner; Jonathan R Seckl; Brian R Walker
Journal:  Bioorg Med Chem Lett       Date:  2010-04-18       Impact factor: 2.823

2.  A life in new drug research.

Authors:  James Black
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

3.  A life in new drug research.

Authors:  James Black
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Exploring Modifications of an HIV-1 Capsid Inhibitor: Design, Synthesis, and Mechanism of Action.

Authors:  Jimmy P Xu; Ashwanth C Francis; Megan E Meuser; Marie Mankowski; Roger G Ptak; Adel A Rashad; Gregory B Melikyan; Simon Cocklin
Journal:  J Drug Des Res       Date:  2018-08-13

5.  Development and validation of an improved algorithm for overlaying flexible molecules.

Authors:  Robin Taylor; Jason C Cole; David A Cosgrove; Eleanor J Gardiner; Valerie J Gillet; Oliver Korb
Journal:  J Comput Aided Mol Des       Date:  2012-04-27       Impact factor: 3.686

6.  The continuous molecular fields approach to building 3D-QSAR models.

Authors:  Igor I Baskin; Nelly I Zhokhova
Journal:  J Comput Aided Mol Des       Date:  2013-05-30       Impact factor: 3.686

Review 7.  Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2015-09-15       Impact factor: 4.932

8.  Alpha shapes applied to molecular shape characterization exhibit novel properties compared to established shape descriptors.

Authors:  J Anthony Wilson; Andreas Bender; Taner Kaya; Paul A Clemons
Journal:  J Chem Inf Model       Date:  2009-10       Impact factor: 4.956

9.  Identification of novel small-molecule agonists for human formyl peptide receptors and pharmacophore models of their recognition.

Authors:  Liliya N Kirpotina; Andrei I Khlebnikov; Igor A Schepetkin; Richard D Ye; Marie-Josèphe Rabiet; Mark A Jutila; Mark T Quinn
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

10.  BCL::MolAlign: Three-Dimensional Small Molecule Alignment for Pharmacophore Mapping.

Authors:  Benjamin P Brown; Jeffrey Mendenhall; Jens Meiler
Journal:  J Chem Inf Model       Date:  2019-02-12       Impact factor: 4.956

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.